Enzymax DuoBiotics for Irritable Bowel Syndrome

Clinical trial NCT07716852 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07716852
Sponsor: Gala Servicios Clinicos S.L.
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Irritable Bowel Syndrome (IBS)

Start date: 2026-09-30
Primary completion: 2027-06-23
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.